Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: A position paper on behalf of the SIGENP IBD working group
- PMID: 33132063
- PMCID: PMC7580561
- DOI: 10.1016/j.dld.2020.10.024
Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: A position paper on behalf of the SIGENP IBD working group
Abstract
Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2, spreading in Italy during the first months of 2020, abruptly changed the way of practicing medicine in this country. As a consequence of the lockdown, the diagnostic and therapeutic management of paediatric chronic conditions, such as inflammatory bowel disease (IBD) has been affected. During the peak of COVID-19 pandemic, elective visits, endoscopies and infusions have been postponed, with potential clinical and psychological impact on disease course and a high likelihood of increasing waiting lists. While slowly moving back towards normality, clinicians need to recognize the best ways to care for patients with IBD, carefully avoiding risk factors for new potential epidemic outbreaks. In this uncertain scenario until the development and spread of COVID-19 vaccine, it is necessary to continue to operate with caution. Hereby we provide useful indications for a safer and gradual restarting of routine clinical activities after COVID-19 peak in Italy.
Keywords: COVID-19; Inflammatory bowel disease; Paediatrics; SARS-CoV2.
Copyright © 2020 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors have no conflict of interest to declare.
Similar articles
-
Pediatric Gastroenterology and Hepatology in Italy before and after the COVID-19: Lessons learned and management changes by SIGENP.Ital J Pediatr. 2023 Jan 26;49(1):15. doi: 10.1186/s13052-023-01418-7. Ital J Pediatr. 2023. PMID: 36698148 Free PMC article. Review.
-
Impact of COVID-19 pandemic on the management of paediatric inflammatory bowel disease: An Italian multicentre study on behalf of the SIGENP IBD Group.Dig Liver Dis. 2021 Mar;53(3):283-288. doi: 10.1016/j.dld.2020.12.011. Epub 2020 Dec 26. Dig Liver Dis. 2021. PMID: 33388247 Free PMC article.
-
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care.United European Gastroenterol J. 2020 Dec;8(10):1228-1235. doi: 10.1177/2050640620964132. Epub 2020 Oct 18. United European Gastroenterol J. 2020. PMID: 33070758 Free PMC article.
-
Impact of COVID-19 on diagnosis and management of paediatric inflammatory bowel disease during lockdown: a UK nationwide study.Arch Dis Child. 2020 Dec;105(12):1186-1191. doi: 10.1136/archdischild-2020-319751. Epub 2020 Jul 30. Arch Dis Child. 2020. PMID: 32732316
-
The Greek Response to COVID-19: A True Success Story from an IBD Perspective.Inflamm Bowel Dis. 2020 Jul 17;26(8):1144-1148. doi: 10.1093/ibd/izaa143. Inflamm Bowel Dis. 2020. PMID: 32476001 Free PMC article. Review.
Cited by
-
Pediatric Gastroenterology and Hepatology in Italy before and after the COVID-19: Lessons learned and management changes by SIGENP.Ital J Pediatr. 2023 Jan 26;49(1):15. doi: 10.1186/s13052-023-01418-7. Ital J Pediatr. 2023. PMID: 36698148 Free PMC article. Review.
-
Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic.Gut. 2022 Jul;71(7):1426-1439. doi: 10.1136/gutjnl-2021-326784. Epub 2022 Apr 27. Gut. 2022. PMID: 35477864 Free PMC article. Review.
-
Gastrointestinal involvement in paediatric COVID-19 - from pathogenesis to clinical management: A comprehensive review.World J Gastroenterol. 2021 Jun 21;27(23):3303-3316. doi: 10.3748/wjg.v27.i23.3303. World J Gastroenterol. 2021. PMID: 34163113 Free PMC article. Review.
-
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Health Care Delivery During the Pandemic and the Future Model of Inflammatory Bowel Disease Care.J Can Assoc Gastroenterol. 2021 Oct 26;4(Suppl 2):S61-S67. doi: 10.1093/jcag/gwab034. eCollection 2021 Dec. J Can Assoc Gastroenterol. 2021. PMID: 34755041 Free PMC article.
-
Implications of SARS-COV-2 infection in the diagnosis and management of the pediatric gastrointestinal disease.Ital J Pediatr. 2021 Mar 24;47(1):71. doi: 10.1186/s13052-021-01020-9. Ital J Pediatr. 2021. PMID: 33761992 Free PMC article. Review.
References
-
- Rosenbaum L. Facing Covid-19 in Italy - ethics, logistics, and therapeutics on the epidemic's front line. N Engl J Med. 2020;382:1873–1875. - PubMed
-
- Scaldaferri F., Pugliese D., Privitera G. Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: reorganisational response in a high-volume Italian inflammatory bowel disease centre. United European Gastroenterol J. 2020;8:775–781. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous